Showing results (241-250 of 258) with videos related to

Sort By:
Pageof 26
Journal of Medicinal Chemistry|February 12, 2000
Design and synthesis of piperazine-based matrix metalloproteinase inhibitorsM Cheng, B De, S Pikul, et al.
Faraday Discussions|July 30, 2016
In situ studies of materials for high temperature CO2 capture and storageMatthew T Dunstan, Serena A Maugeri, Wen Liu, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 18, 2024
A Stepped-Wedge, Cluster-Randomized, Multisite Study of Text Messaging Plus Peer Navigation to Improve Adherence and Viral Suppression Among Youth on Antiretroviral TherapyBabafemi O Taiwo, Lisa M Kuhns, Oche Agbaji, et al.
Medrxiv : the Preprint Server for Health Sciences|April 21, 2021
Coincident rapid expansion of two SARS-CoV-2 lineages with enhanced infectivity in NigeriaEgon A Ozer, Lacy M Simons, Olubusuyi M Adewumi, et al.
Journal of Clinical and Translational Science|November 14, 2024
Engaging communities in therapeutics clinical research during pandemics: Experiences and lessons from the ACTIV COVID-19 therapeutics research initiativeDavid A Wohl, Stacey J Adam, Kevin W Gibbs, et al.
The Journal of Infectious Diseases|January 20, 2023
Phase 2 Safety and Antiviral Activity of SAB-185, a Novel Polyclonal Antibody Therapy for Nonhospitalized Adults With COVID-19Babafemi O Taiwo, Kara W Chew, Carlee Moser, et al.
JACC. Heart Failure|April 13, 2020
Differential Associations of Chronic Inflammatory Diseases With Incident Heart FailureSameer Prasada, Adovich Rivera, Arvind Nishtala, et al.
Journal of Stomatology, Oral and Maxillofacial Surgery|January 1, 2026
Magnitude and Predictors of Psychological Burden of Care among Informal Caregivers of Noma SurvivorsA I Yakubu, M Bala, R O Braimah, et al.
The Journal of Infectious Diseases|July 19, 2024
Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical TrialKara W Chew, Babafemi O Taiwo, Carlee Moser, et al.
Pageof 26